N
RVMD icon

Natixis’s Revolution Medicines RVMD Stock Holding History

Natixis’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$461K Sell
4,745
-7,714
-62% -$779K ﹤0.01% 823
2025
Q4 		$992K Buy
+12,459
New +$817K ﹤0.01% 722
2025
Q1 		– Sell
-1,170
Closed -$51.2K – 1164
2024
Q4 		$51.2K Sell
1,170
-83,624
-99% -$4.22M ﹤0.01% 881
2024
Q3 		$3.85M Buy
84,794
+83,325
+5,672% +$3.63M 0.02% 348
2024
Q2 		$57K Sell
1,469
-4,606
-76% -$172K ﹤0.01% 779
2024
Q1 		$196K Buy
+6,075
New +$180K ﹤0.01% 718
2022
Q1 		– Sell
-13,200
Closed -$332K – 1309
2021
Q4 		$332K Buy
+13,200
New +$372K ﹤0.01% 1114

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return